Joint Action EUROCAT 2011-2013 Funded by the Public Health Programme 2008-2013 of the European Commission

Ingeborg Barisic; Maria Loane; Rhonda M Curran; Ester Garne; Martine Vrijheid; Domenica Taruscio; Joan Morris; Marian Bakker; Lorentz Irgens; Elisa Calzolari; Babak Khoshnood; Diana Wellesley; Helen Dolk

Joint Action EUROCAT 2011-2013 Funded by the Public Health Programme 2008-2013 of the European Commission

Ingeborg Barisic, Maria Loane, Rhonda M Curran, Ester Garne, Martine Vrijheid, Domenica Taruscio, Joan Morris, Marian Bakker, Lorentz Irgens, Elisa Calzolari, Babak Khoshnood, Diana Wellesley, Helen Dolk

Research output: Contribution to journal › Article › peer-review

Abstract

Congenital anomalies (CA) are an important cause of morbidity and mortality in infants and children. More than 100,000 children with CA are born in EU each year. The European Surveillance of Congenital Anomalies (EUROCAT) is a network of population based congenital anomaly registries in Europe currently surveying 31% of EU birth population. EUROCAT has been awarded funding for 2011-2013 as a Joint Action between EU and member states. The Joint Action EUROCAT aims to use harmonised data on CA across EU to assess prevalence of all birth outcomes, the impact of primary prevention, and developments in prenatal screening. Joint Action EUROCAT will serve as an early warning of teratogen exposures, and act as an information centre regarding clusters, and exposures to risk factors of concern, including new medicine used in pregnancy, ail pollution, swine flu vaccination, and chronic maternal diseases as obesity and diabetes.

Original language	English
Pages (from-to)	25-32
Journal	Hrvatski časopis za javno zdravstvo
Volume	8
Publication status	Published (in print/issue) - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Cite this

Barisic, I., Loane, M., Curran, R. M., Garne, E., Vrijheid, M., Taruscio, D., Morris, J., Bakker, M., Irgens, L., Calzolari, E., Khoshnood, B., Wellesley, D., & Dolk, H. (2012). Joint Action EUROCAT 2011-2013 Funded by the Public Health Programme 2008-2013 of the European Commission. Hrvatski časopis za javno zdravstvo, 8, 25-32. http://uir.ulster.ac.uk/23703/1/JA_paper.pdf

@article{5d1b38ef7a344e4587089b24b38e8cc4,

title = "Joint Action EUROCAT 2011-2013 Funded by the Public Health Programme 2008-2013 of the European Commission",

abstract = "Congenital anomalies (CA) are an important cause of morbidity and mortality in infants and children. More than 100,000 children with CA are born in EU each year. The European Surveillance of Congenital Anomalies (EUROCAT) is a network of population based congenital anomaly registries in Europe currently surveying 31% of EU birth population. EUROCAT has been awarded funding for 2011-2013 as a Joint Action between EU and member states. The Joint Action EUROCAT aims to use harmonised data on CA across EU to assess prevalence of all birth outcomes, the impact of primary prevention, and developments in prenatal screening. Joint Action EUROCAT will serve as an early warning of teratogen exposures, and act as an information centre regarding clusters, and exposures to risk factors of concern, including new medicine used in pregnancy, ail pollution, swine flu vaccination, and chronic maternal diseases as obesity and diabetes.",

author = "Ingeborg Barisic and Maria Loane and Curran, {Rhonda M} and Ester Garne and Martine Vrijheid and Domenica Taruscio and Joan Morris and Marian Bakker and Lorentz Irgens and Elisa Calzolari and Babak Khoshnood and Diana Wellesley and Helen Dolk",

year = "2012",

language = "English",

volume = "8",

pages = "25--32",

journal = "Hrvatski {\v c}asopis za javno zdravstvo",

issn = "1845-3082",

publisher = "Croatian Institute of Public Health",

}

Barisic, I, Loane, M, Curran, RM, Garne, E, Vrijheid, M, Taruscio, D, Morris, J, Bakker, M, Irgens, L, Calzolari, E, Khoshnood, B, Wellesley, D & Dolk, H 2012, 'Joint Action EUROCAT 2011-2013 Funded by the Public Health Programme 2008-2013 of the European Commission', Hrvatski časopis za javno zdravstvo, vol. 8, pp. 25-32. <http://uir.ulster.ac.uk/23703/1/JA_paper.pdf>

TY - JOUR

T1 - Joint Action EUROCAT 2011-2013 Funded by the Public Health Programme 2008-2013 of the European Commission

AU - Barisic, Ingeborg

AU - Loane, Maria

AU - Curran, Rhonda M

AU - Garne, Ester

AU - Vrijheid, Martine

AU - Taruscio, Domenica

AU - Morris, Joan

AU - Bakker, Marian

AU - Irgens, Lorentz

AU - Calzolari, Elisa

AU - Khoshnood, Babak

AU - Wellesley, Diana

AU - Dolk, Helen

PY - 2012

Y1 - 2012

N2 - Congenital anomalies (CA) are an important cause of morbidity and mortality in infants and children. More than 100,000 children with CA are born in EU each year. The European Surveillance of Congenital Anomalies (EUROCAT) is a network of population based congenital anomaly registries in Europe currently surveying 31% of EU birth population. EUROCAT has been awarded funding for 2011-2013 as a Joint Action between EU and member states. The Joint Action EUROCAT aims to use harmonised data on CA across EU to assess prevalence of all birth outcomes, the impact of primary prevention, and developments in prenatal screening. Joint Action EUROCAT will serve as an early warning of teratogen exposures, and act as an information centre regarding clusters, and exposures to risk factors of concern, including new medicine used in pregnancy, ail pollution, swine flu vaccination, and chronic maternal diseases as obesity and diabetes.

AB - Congenital anomalies (CA) are an important cause of morbidity and mortality in infants and children. More than 100,000 children with CA are born in EU each year. The European Surveillance of Congenital Anomalies (EUROCAT) is a network of population based congenital anomaly registries in Europe currently surveying 31% of EU birth population. EUROCAT has been awarded funding for 2011-2013 as a Joint Action between EU and member states. The Joint Action EUROCAT aims to use harmonised data on CA across EU to assess prevalence of all birth outcomes, the impact of primary prevention, and developments in prenatal screening. Joint Action EUROCAT will serve as an early warning of teratogen exposures, and act as an information centre regarding clusters, and exposures to risk factors of concern, including new medicine used in pregnancy, ail pollution, swine flu vaccination, and chronic maternal diseases as obesity and diabetes.

M3 - Article

VL - 8

SP - 25

EP - 32

JO - Hrvatski časopis za javno zdravstvo

JF - Hrvatski časopis za javno zdravstvo

SN - 1845-3082

ER -

Joint Action EUROCAT 2011-2013 Funded by the Public Health Programme 2008-2013 of the European Commission

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this